Status:
UNKNOWN
Autophagy Bladder Cancer
Lead Sponsor:
Assiut University
Conditions:
Bladder Cancer
Eligibility:
All Genders
Brief Summary
• Bladder cancer is the most common malignancy of the urinary tract. It represents the 7th most commonly diagnosed cancer in male population worldwide and drops to the 11th when both genders are consi...
Detailed Description
* In Egypt, Bladder Cancer is the most prevalent malignancy among Egyptian males (16%) producing more than 7900 deaths annually . The majority of patients with bladder cancer about (70-80%) present wi...
Eligibility Criteria
Inclusion
- 1)patients confirmed histopathologically to have bladder cancer. 2) Both sexes. 3) Patients who will accept to participate in the study.
Exclusion
- Patients with past history of Bladder Cancer with previous chemotherapy or any other types of cancer in the last 5 years.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03254888
Start Date
December 1 2020
End Date
December 31 2021
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut
Asyut, Egypt, 71111